Andrew C. Lee
State Key Laboratory Of Emerging Infectious Diseases, Pokfulam
Sar, China
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB/c mice.
Journal: Emerging microbes & infections
Published: March 04, 2025
Prevalence, Classification and Factors Associated With Cemental Tears-A Retrospective Observational Cross-Sectional Study in a Postgraduate Endodontic Clinic.
Journal: International endodontic journal
Published: December 23, 2024
Chronic lung inflammation and CK14+ basal cell proliferation induce persistent alveolar-bronchiolization in SARS-CoV-2-infected hamsters.
Journal: EBioMedicine
Published: May 21, 2024
An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models.
Journal: Nature communications
Published: May 18, 2023
Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly weaned hamsters.
Journal: Emerging microbes & infections
Published: May 01, 2023
COVID-19 mRNA vaccine protects against SARS-CoV-2 Omicron BA.1 infection in diet-induced obese mice through boosting host innate antiviral responses.
Journal: EBioMedicine
Published: November 22, 2022
STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells.
Journal: Emerging microbes & infections
Published: May 12, 2021
Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 15, 2021
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges.
Journal: NPJ vaccines
Published: December 10, 2020
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Journal: Cell
Published: December 01, 2020
Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine.
Journal: Vaccines
Published: November 18, 2020
Last Updated: 09/26/2026